HIGHLIGHTS
- who: Sarwat Mahmud from the (UNIVERSITY) have published the article: Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries, in the Journal: BMC Medicine
- what: This paper presents an overview of the RSV component of UNIVAC, synthesises RSV model input parameters for 133 LMICs, compares the cost-effectiveness results of UNIVAC to a separate model published by PATH , and identifies the inputs with the largest influence on the cost-effectiveness results. The paper is not intended as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.